Publicaciones en colaboración con investigadores/as de University of North Carolina at Chapel Hill (16)

2024

  1. International Consensus Recommendations for Safe Use of LAMS for On- and Off-Label Indications Using a Modified Delphi Process

    American Journal of Gastroenterology, Vol. 119, Núm. 4, pp. 671-681

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. The endoscopic ultrasound features of pancreatic fluid collections and their impact on therapeutic decisions: An interobserver agreement study

    Endoscopy, Vol. 54, Núm. 6, pp. 555-562

  3. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  2. Sand dollar sign

    Gastrointestinal Endoscopy

2020

  1. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

2016

  1. Evaluation of the short- and long-term effectiveness and safety of fully covered self-expandable metal stents for drainage of pancreatic fluid collections: results of a Spanish nationwide registry

    Gastrointestinal Endoscopy, Vol. 84, Núm. 3, pp. 450-457.e2

2013

  1. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

    PLoS Genetics, Vol. 9, Núm. 3

  2. Heredity and cardiometabolic risk: Naturally occurring polymorphisms in the human neuropeptide Y2 receptor promoter disrupt multiple transcriptional response motifs

    Journal of Hypertension, Vol. 31, Núm. 1, pp. 123-133

  3. MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: Functional andtherapeutic implications forgeneexpressionand the pathogenesis of hypertension

    Human Molecular Genetics, Vol. 22, Núm. 18, pp. 3624-3640

2012

  1. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

    Cancer Epidemiology Biomarkers and Prevention, Vol. 21, Núm. 4, pp. 645-657

  2. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

    Human Mutation, Vol. 33, Núm. 4, pp. 690-702

2010

  1. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

    Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754

  2. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer

    PLoS Genetics, Vol. 6, Núm. 10, pp. 1-12